| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 1.14e-11 | 44 | 50 | 7 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 2.52e-11 | 49 | 50 | 7 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.58e-10 | 63 | 50 | 7 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.54e-08 | 129 | 50 | 7 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.03e-07 | 158 | 50 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 6.42e-07 | 207 | 50 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 2.86e-06 | 259 | 50 | 7 | GO:1903313 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.35e-05 | 358 | 50 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.35e-05 | 358 | 50 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.53e-05 | 362 | 50 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 3.44e-05 | 4 | 50 | 2 | GO:0031587 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 9.05e-05 | 443 | 50 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1.20e-04 | 7 | 50 | 2 | GO:0031585 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.96e-04 | 502 | 50 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 2.06e-04 | 224 | 50 | 5 | GO:0051650 | |
| GeneOntologyBiologicalProcess | vesicle localization | 3.23e-04 | 247 | 50 | 5 | GO:0051648 | |
| GeneOntologyBiologicalProcess | mRNA processing | 3.45e-04 | 551 | 50 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | urea cycle | 4.42e-04 | 13 | 50 | 2 | GO:0000050 | |
| GeneOntologyBiologicalProcess | positive regulation of non-motile cilium assembly | 4.42e-04 | 13 | 50 | 2 | GO:1902857 | |
| GeneOntologyBiologicalProcess | urea metabolic process | 5.93e-04 | 15 | 50 | 2 | GO:0019627 | |
| GeneOntologyBiologicalProcess | nitrogen cycle metabolic process | 5.93e-04 | 15 | 50 | 2 | GO:0071941 | |
| GeneOntologyBiologicalProcess | postsynapse to nucleus signaling pathway | 6.76e-04 | 16 | 50 | 2 | GO:0099527 | |
| GeneOntologyBiologicalProcess | gonad development | 6.91e-04 | 292 | 50 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 7.46e-04 | 297 | 50 | 5 | GO:0045137 | |
| GeneOntologyBiologicalProcess | male gonad development | 7.80e-04 | 171 | 50 | 4 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 7.97e-04 | 172 | 50 | 4 | GO:0046546 | |
| GeneOntologyBiologicalProcess | regulation of non-motile cilium assembly | 8.60e-04 | 18 | 50 | 2 | GO:1902855 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, GABAergic | 1.06e-03 | 20 | 50 | 2 | GO:0032230 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.20e-05 | 215 | 50 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 5.32e-05 | 86 | 50 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.54e-04 | 113 | 50 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | inclusion body | 1.31e-03 | 90 | 50 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | INTS6L KMT2C RBMY1A1 RBMY1C RBMY1F RBMY1D NUP98 RBMY1B RBMY1E SAMD7 | 1.36e-03 | 1377 | 50 | 10 | GO:0140513 |
| Domain | RBM1CTR | 4.03e-12 | 8 | 46 | 5 | PF08081 | |
| Domain | RBM1CTR | 4.03e-12 | 8 | 46 | 5 | IPR012604 | |
| Domain | RRM_1 | 1.54e-04 | 208 | 46 | 5 | PF00076 | |
| Domain | RRM | 1.88e-04 | 217 | 46 | 5 | SM00360 | |
| Domain | RRM_dom | 2.32e-04 | 227 | 46 | 5 | IPR000504 | |
| Domain | RRM | 2.46e-04 | 230 | 46 | 5 | PS50102 | |
| Domain | C2 | 3.00e-04 | 131 | 46 | 4 | PF00168 | |
| Domain | C2 | 3.56e-04 | 137 | 46 | 4 | SM00239 | |
| Domain | C2 | 4.08e-04 | 142 | 46 | 4 | PS50004 | |
| Domain | Nucleotide-bd_a/b_plait | 4.18e-04 | 258 | 46 | 5 | IPR012677 | |
| Domain | - | 4.77e-04 | 148 | 46 | 4 | 2.60.40.150 | |
| Domain | AT_hook | 6.97e-04 | 16 | 46 | 2 | PF02178 | |
| Domain | C2_dom | 7.02e-04 | 164 | 46 | 4 | IPR000008 | |
| Domain | Synaptotagmin | 1.10e-03 | 20 | 46 | 2 | IPR001565 | |
| Domain | AT_hook | 2.00e-03 | 27 | 46 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.00e-03 | 27 | 46 | 2 | IPR017956 | |
| Domain | HMGI/Y_DNA-bd_CS | 2.64e-03 | 31 | 46 | 2 | IPR000637 | |
| Domain | - | 3.02e-03 | 244 | 46 | 4 | 3.30.70.330 | |
| Domain | Znf_FYVE-rel | 3.17e-03 | 34 | 46 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 3.94e-03 | 38 | 46 | 2 | IPR000306 | |
| Domain | ARM-like | 4.33e-03 | 270 | 46 | 4 | IPR011989 | |
| Domain | ZF_FYVE | 4.36e-03 | 40 | 46 | 2 | PS50178 | |
| Domain | Znf_FYVE_PHD | 5.66e-03 | 147 | 46 | 3 | IPR011011 | |
| Domain | ARM-type_fold | 9.55e-03 | 339 | 46 | 4 | IPR016024 | |
| Pubmed | 4.52e-17 | 7 | 50 | 6 | 8269511 | ||
| Pubmed | 5.94e-15 | 12 | 50 | 6 | 9598316 | ||
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 1.05e-13 | 7 | 50 | 5 | 8875892 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 1.89e-11 | 5 | 50 | 4 | 8817321 | |
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 1.89e-11 | 5 | 50 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 1.89e-11 | 5 | 50 | 4 | 19737860 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 5.66e-11 | 6 | 50 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 5.66e-11 | 6 | 50 | 4 | 12356914 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 9499427 | ||
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 15051956 | ||
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.32e-10 | 7 | 50 | 4 | 10377282 | |
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 7479793 | ||
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 10601091 | ||
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 1.85e-09 | 12 | 50 | 4 | 20543856 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 2.68e-09 | 13 | 50 | 4 | 23816659 | |
| Pubmed | 2.68e-09 | 13 | 50 | 4 | 10749975 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 3.74e-09 | 14 | 50 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 5.10e-09 | 15 | 50 | 4 | 14762062 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 8.87e-09 | 17 | 50 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.14e-08 | 18 | 50 | 4 | 12023983 | |
| Pubmed | 5.52e-08 | 26 | 50 | 4 | 35920200 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.22e-06 | 55 | 50 | 4 | 19468303 | |
| Pubmed | 1.62e-06 | 59 | 50 | 4 | 11279525 | ||
| Pubmed | A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. | 2.03e-06 | 2 | 50 | 2 | 9668110 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.03e-06 | 2 | 50 | 2 | 32473614 | |
| Pubmed | Association of HAP1 isoforms with a unique cytoplasmic structure. | 2.03e-06 | 2 | 50 | 2 | 9798945 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24453320 | ||
| Pubmed | A huntingtin-associated protein enriched in brain with implications for pathology. | 2.03e-06 | 2 | 50 | 2 | 7477378 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9599014 | ||
| Pubmed | 5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. | 2.03e-06 | 2 | 50 | 2 | 15857891 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20515468 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22589249 | ||
| Pubmed | Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. | 2.03e-06 | 2 | 50 | 2 | 18192679 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15496430 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10974549 | ||
| Pubmed | Interaction of huntingtin-associated protein with dynactin P150Glued. | 6.07e-06 | 3 | 50 | 2 | 9454836 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11971876 | ||
| Pubmed | Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice. | 6.07e-06 | 3 | 50 | 2 | 32747555 | |
| Pubmed | 1.09e-05 | 95 | 50 | 4 | 24029230 | ||
| Pubmed | Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. | 1.21e-05 | 4 | 50 | 2 | 21985783 | |
| Pubmed | Polyglutamine expansion of huntingtin impairs its nuclear export. | 1.21e-05 | 4 | 50 | 2 | 15654337 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 22179316 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 17868456 | ||
| Pubmed | Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. | 1.21e-05 | 4 | 50 | 2 | 12881483 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 23375656 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 15242649 | ||
| Pubmed | The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. | 2.52e-05 | 241 | 50 | 5 | 12815422 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 18922795 | ||
| Pubmed | Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. | 5.64e-05 | 8 | 50 | 2 | 30994454 | |
| Pubmed | RNA association and nucleocytoplasmic shuttling by ataxin-1. | 5.64e-05 | 8 | 50 | 2 | 15615787 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 8901523 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 10332027 | ||
| Pubmed | 1.41e-04 | 347 | 50 | 5 | 16033648 | ||
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 9502734 | ||
| Pubmed | Huntingtin functions as a scaffold for selective macroautophagy. | 2.10e-04 | 15 | 50 | 2 | 25686248 | |
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 22183742 | ||
| Pubmed | 4.34e-04 | 102 | 50 | 3 | 9734811 | ||
| Pubmed | 4.47e-04 | 103 | 50 | 3 | 10819331 | ||
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 7.15e-04 | 121 | 50 | 3 | 31900314 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 9.77e-04 | 32 | 50 | 2 | 31434798 | |
| Interaction | RBMY1J interactions | 6.44e-07 | 29 | 48 | 4 | int:RBMY1J | |
| Interaction | RBMY1F interactions | 1.58e-06 | 36 | 48 | 4 | int:RBMY1F | |
| Interaction | RBMY1E interactions | 3.32e-05 | 4 | 48 | 2 | int:RBMY1E | |
| Interaction | RBMY1A1 interactions | 5.99e-05 | 32 | 48 | 3 | int:RBMY1A1 | |
| Cytoband | Yq11.223 | 6.03e-08 | 93 | 50 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 2.28e-05 | 311 | 50 | 5 | chrYq11 | |
| Cytoband | Xq26.3 | 2.46e-03 | 67 | 50 | 2 | Xq26.3 | |
| GeneFamily | RNA binding motif containing | 5.02e-06 | 213 | 38 | 6 | 725 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 3.89e-07 | 33 | 48 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 1.40e-06 | 45 | 48 | 4 | MM763 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 177 | 46 | 5 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-05 | 166 | 46 | 4 | 688e3c01ffcec01eb7027df6f3bde8fecfb50479 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 168 | 46 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-05 | 170 | 46 | 4 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-05 | 171 | 46 | 4 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 174 | 46 | 4 | 93a0dd37d648fcb29654be70f631eee2915f682e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 175 | 46 | 4 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.25e-05 | 176 | 46 | 4 | 9a4cef3dc88f64a71b91ab4790ea19334afee3ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-05 | 177 | 46 | 4 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 178 | 46 | 4 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-05 | 179 | 46 | 4 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 181 | 46 | 4 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 181 | 46 | 4 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 46 | 4 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-05 | 184 | 46 | 4 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 185 | 46 | 4 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-05 | 186 | 46 | 4 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.38e-05 | 190 | 46 | 4 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.38e-05 | 190 | 46 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 4.38e-05 | 190 | 46 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.47e-05 | 191 | 46 | 4 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-05 | 192 | 46 | 4 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-05 | 192 | 46 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 46 | 4 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-05 | 193 | 46 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-05 | 193 | 46 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 4.75e-05 | 194 | 46 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 4.75e-05 | 194 | 46 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.75e-05 | 194 | 46 | 4 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.81e-04 | 137 | 46 | 3 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.41e-04 | 144 | 46 | 3 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | severe_COVID-19-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 5.26e-04 | 153 | 46 | 3 | 422483445af49c277fc8962d76a46ffafd872422 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-5|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.67e-04 | 157 | 46 | 3 | 59450e9f580555091b159fbbe0a0756e51bcd9ad | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.88e-04 | 159 | 46 | 3 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-04 | 159 | 46 | 3 | 51a7322efead3d4978e8f9fef71302bfae96edd7 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.10e-04 | 161 | 46 | 3 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.32e-04 | 163 | 46 | 3 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.32e-04 | 163 | 46 | 3 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-04 | 164 | 46 | 3 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-04 | 164 | 46 | 3 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.43e-04 | 164 | 46 | 3 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-04 | 164 | 46 | 3 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 6.55e-04 | 165 | 46 | 3 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 165 | 46 | 3 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.66e-04 | 166 | 46 | 3 | 8ac0a769be886d16642e7e6334471ebadd1a426b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.78e-04 | 167 | 46 | 3 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.78e-04 | 167 | 46 | 3 | 806d1c00c137da0c5f042adf866873eb6dd4bb27 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.78e-04 | 167 | 46 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-04 | 168 | 46 | 3 | 237a6a6e3bd3ed0e9f24a964b939bfdad442fc19 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-04 | 168 | 46 | 3 | 2ab11cb9e691ac363e81f985e0450cdd721f9d7a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 169 | 46 | 3 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 7.02e-04 | 169 | 46 | 3 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 169 | 46 | 3 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.02e-04 | 169 | 46 | 3 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.26e-04 | 171 | 46 | 3 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 7.26e-04 | 171 | 46 | 3 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 7.39e-04 | 172 | 46 | 3 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-04 | 172 | 46 | 3 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-04 | 172 | 46 | 3 | 1bbf5ed7d13635f9a7e528060341e0652699bd7c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-04 | 174 | 46 | 3 | 62f5dc7086e1491fc90f005ccadfa1b772b52fad | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.64e-04 | 174 | 46 | 3 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.76e-04 | 175 | 46 | 3 | 4d42a97c450e919a409477a7db85e2668f0d473b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-04 | 175 | 46 | 3 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.76e-04 | 175 | 46 | 3 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.76e-04 | 175 | 46 | 3 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.76e-04 | 175 | 46 | 3 | 8252ddc2ca95071381f0354aefb70c4714828491 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.76e-04 | 175 | 46 | 3 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.76e-04 | 175 | 46 | 3 | 8ccf60fc469059d7aaf4e6ce54159db2962e0060 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.89e-04 | 176 | 46 | 3 | 23f930dac5247ea6d4124da33933d61ad6e089af | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.02e-04 | 177 | 46 | 3 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-04 | 177 | 46 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-04 | 177 | 46 | 3 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 8.02e-04 | 177 | 46 | 3 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-04 | 177 | 46 | 3 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-04 | 177 | 46 | 3 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-04 | 177 | 46 | 3 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-04 | 177 | 46 | 3 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-04 | 178 | 46 | 3 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-04 | 178 | 46 | 3 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.16e-04 | 178 | 46 | 3 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 8.16e-04 | 178 | 46 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.29e-04 | 179 | 46 | 3 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-04 | 179 | 46 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 8.29e-04 | 179 | 46 | 3 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.29e-04 | 179 | 46 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-04 | 180 | 46 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 8.42e-04 | 180 | 46 | 3 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.56e-04 | 181 | 46 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.56e-04 | 181 | 46 | 3 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.56e-04 | 181 | 46 | 3 | 42f5a645beeb5a1a746d79ea7fe7fd3786fd35ad | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-04 | 182 | 46 | 3 | c98da2db197b1531204e116600ff51891e5c17af | |
| Drug | PKI166 | 4.82e-08 | 48 | 47 | 5 | CID006918403 | |
| Drug | hydantoin-5-propionic acid | 9.29e-08 | 21 | 47 | 4 | CID000000782 | |
| Drug | AZFd | 1.37e-07 | 23 | 47 | 4 | CID000196489 | |
| Drug | Vistar | 8.94e-07 | 36 | 47 | 4 | CID000040896 | |
| Drug | 2-chlorodideoxyadenosine | 1.85e-06 | 43 | 47 | 4 | CID000072194 | |
| Drug | HgCl | 3.15e-06 | 49 | 47 | 4 | CID000024182 | |
| Drug | azafagomine | 5.81e-06 | 57 | 47 | 4 | CID011957435 | |
| Drug | thioglycolate | 1.11e-05 | 67 | 47 | 4 | CID000001133 | |
| Drug | SU6668 | 1.32e-05 | 70 | 47 | 4 | CID000206042 | |
| Drug | taxol | 1.72e-05 | 560 | 47 | 8 | CID000004666 | |
| Drug | p11-13 | 1.74e-05 | 75 | 47 | 4 | CID000015759 | |
| Drug | oligoadenylate | 1.78e-05 | 157 | 47 | 5 | CID000107918 | |
| Drug | glutamin | 4.16e-05 | 461 | 47 | 7 | CID000000738 | |
| Drug | bipy | 4.80e-05 | 97 | 47 | 4 | CID000001474 | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A | 5.14e-05 | 196 | 47 | 5 | 3889_UP | |
| Drug | Hhap | 6.22e-05 | 6 | 47 | 2 | CID000123902 | |
| Drug | 2-oyl | 6.54e-05 | 105 | 47 | 4 | CID000657137 | |
| Drug | carbonyl sulfide | 9.63e-05 | 116 | 47 | 4 | CID000010039 | |
| Disease | cervical artery dissection | 2.53e-04 | 17 | 41 | 2 | EFO_1000059 | |
| Disease | non-high density lipoprotein cholesterol measurement | 4.26e-04 | 713 | 41 | 6 | EFO_0005689 | |
| Disease | Huntington's disease (is_implicated_in) | 4.68e-04 | 23 | 41 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | stomach carcinoma (is_marker_for) | 5.10e-04 | 24 | 41 | 2 | DOID:5517 (is_marker_for) | |
| Disease | dementia, Alzheimer's disease neuropathologic change | 1.03e-03 | 34 | 41 | 2 | EFO_0006801, MONDO_0001627 | |
| Disease | personality trait | 1.35e-03 | 39 | 41 | 2 | EFO_0004365 | |
| Disease | uric acid measurement | 1.51e-03 | 610 | 41 | 5 | EFO_0004761 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.80e-03 | 45 | 41 | 2 | DOID:3748 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.13e-03 | 49 | 41 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | blood copper measurement | 2.21e-03 | 50 | 41 | 2 | EFO_0007578 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.59e-03 | 197 | 41 | 3 | EFO_0005680 | |
| Disease | mean platelet volume | 2.69e-03 | 1020 | 41 | 6 | EFO_0004584 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.17e-03 | 60 | 41 | 2 | EFO_0022233 | |
| Disease | Intellectual Disability | 3.38e-03 | 447 | 41 | 4 | C3714756 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.96e-03 | 229 | 41 | 3 | EFO_0004639, EFO_0008317 | |
| Disease | fatty acid measurement, linoleic acid measurement | 4.05e-03 | 68 | 41 | 2 | EFO_0005110, EFO_0006807 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 4.17e-03 | 69 | 41 | 2 | EFO_0007788, EFO_0008002 | |
| Disease | visceral:subcutaneous adipose tissue ratio | 4.29e-03 | 70 | 41 | 2 | EFO_0004767 | |
| Disease | Non-alcoholic Fatty Liver Disease | 4.29e-03 | 70 | 41 | 2 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 4.29e-03 | 70 | 41 | 2 | C3241937 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.41e-03 | 71 | 41 | 2 | DOID:0050700 (implicated_via_orthology) | |
| Disease | leucine measurement | 4.65e-03 | 73 | 41 | 2 | EFO_0009770 | |
| Disease | migraine disorder, endometriosis | 4.65e-03 | 73 | 41 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | mean arterial pressure | 4.99e-03 | 499 | 41 | 4 | EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWPPNMTDFSVFSNL | 406 | Q15303 | |
| DPNAQSSFSKSPWAM | 416 | A0A096LP49 | |
| MSFLEQENSSSWPSP | 26 | Q9UGI9 | |
| ELRPSNAFAFWMTPS | 216 | Q9NS82 | |
| SAPSAVARSNSWMGS | 166 | P0DJD3 | |
| SAPSAVARSNSWMGS | 166 | A6NDE4 | |
| SAPSAVARSNSWMGS | 166 | P0DJD4 | |
| SAPSAVARSNSWMGS | 166 | P0C7P1 | |
| SAPSAVARSNSWMGS | 166 | A6NEQ0 | |
| SAPSAVARSNSWMGS | 166 | Q15415 | |
| ASMLSNLDHSQPWSP | 431 | Q9UHI8 | |
| MDSSRPSNSFAAQPW | 251 | Q5JSJ4 | |
| DMSWQSSPSLENPSS | 7081 | Q8WXI7 | |
| PRAASLMNIPSTSSW | 1071 | P52948 | |
| NSAFNPMASDPNNSW | 1601 | Q8NEZ4 | |
| LNQSSSPSQMFPWMR | 176 | P13378 | |
| RPAAMAVAGFSNWTS | 416 | P14672 | |
| PSWANMSLDSSPESA | 276 | Q9NST1 | |
| ALDSNHNMAPPSDWS | 606 | Q8TBB1 | |
| SWFESNDNPEMPSNS | 786 | Q9Y5G1 | |
| SLPSPMFSRNDFSIW | 536 | Q9BXW6 | |
| RSSQLDFQNSPSWPM | 116 | Q96PQ7 | |
| DFQNSPSWPMASTSE | 121 | Q96PQ7 | |
| SQMPDPSNWLSALES | 361 | Q9NYA4 | |
| PSRDQWSMTPQTVNA | 666 | P0DPD8 | |
| NPSAPRCMWSSALNS | 266 | P08571 | |
| SNFTQRAPVAMATWS | 3041 | P42858 | |
| QMENWAPSSPNAEAS | 116 | P27352 | |
| MYLSPPADTSWRRTN | 136 | Q6UUV9 | |
| FWPPNAARMASQNSF | 36 | P07954 | |
| MPDNSDAPWTRFVFQ | 96 | P54257 | |
| DTSMRPRSSAFSWPG | 181 | Q1ZYL8 | |
| AMWTAVFDEPANSTP | 711 | O75170 | |
| MDNASFSEPWPANAS | 1 | P48145 | |
| MALSNSSWRLPQPSF | 16 | Q8NGH6 | |
| CFWPEENANTFSRPM | 356 | Q5JY77 | |
| PNRPDTSFSWFMSPF | 1796 | Q2WGJ9 | |
| MPWRNKEASSPSSAN | 86 | Q5T7P8 | |
| FSNSSNRWMYPSDRP | 6 | Q9Y2J0 | |
| LDPNSWSDTMNIFCP | 416 | Q7Z3H4 | |
| PSAMADSSFRFPRTW | 91 | Q9HB63 | |
| ATRIDSSNPNPLMFW | 1791 | Q9P212 | |
| SQFRSPSWQTAMHTP | 111 | Q9ULL5 | |
| WSAMTNEPETNCNPS | 276 | Q9NRX5 | |
| ASANWTPSISPSMDR | 156 | Q70Z44 | |
| RKMPWQSSNHSFPTS | 566 | Q8TCG1 | |
| NTSTPVDRMSFNLPW | 511 | Q9NUY8 | |
| MSSFSRAPQQWATFA | 1 | Q9BYD1 | |
| PSSSPTFWNYSRSMG | 266 | Q96SK2 | |
| FPEALSSNMSGSFWS | 81 | Q86VR7 | |
| NDDSMSPNQWRYSSP | 71 | Q99990 |